L&C BIO

엘앤씨바이오KRX: 290650· Fiscal year 2025· lncbio.co.kr ↗

Average salary
$34.8K
₩46.3M
▼ 5.7% vs 2024
Employees
155
▲ 14.8% vs 2024
Average tenure
3.5 yrs

Estimated take-home of this pay:$2.5K / monthCalculate →

Workplace

Women's pay (men = 100)66
Women among staff41.9%
Contract staff6.5%

Recent official filings

Quick read

  • Average pay is 24% below the median of the companies we track.
  • Average pay fell 5.7% from 2024.
  • Headcount grew by 20 (14.8%) from 2024.
  • Ranks #208 of 238 Healthcare & Pharma companies in this country by pay.
  • Revenue grew 18.7% year over year.
  • Revenue has grown two years in a row.
  • Operating margin was 5.2% in 2025.

Last 3 years

Revenue
$49.5M2023$54.1M2024$64.2M2025
Operating income
$2.2M2023$2.9M2024$3.3M2025

See the share price on Naver Finance ↗

Investor metrics

2025
Revenue per employee
$412.9K
Net profit per employee
-$667.9K
Operating margin
5.2%
Net margin
-161.7%
ROE
-66.3%
Debt-to-equity
119.0%
Equity ratio
45.7%
Dividend per share
$0
Dividend yield (as disclosed)
0.1%

Per-employee figures use the company headcount, so they run high for groups with many subsidiaries. Not investment advice.

Similar companies

USD at ₩1,332.22 per $1 (2026-11-19, ExchangeRate-API)

Source: DART (Financial Supervisory Service, Korea)

Not investment advice. Figures come from public filings and may contain errors.